BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 2890684)

  • 1. Usefulness of basal catecholamine plasma levels and clonidine suppression test in the diagnosis of pheochromocytoma.
    Mannelli M; De Feo ML; Maggi M; Pupilli C; Opocher G; Valenza T; Baldi E; Serio M
    J Endocrinol Invest; 1987 Aug; 10(4):377-82. PubMed ID: 2890684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the clonidine suppression test in the diagnosis of phaeochromocytoma.
    McHenry CM; Hunter SJ; McCormick MT; Russell CF; Smye MG; Atkinson AB
    J Hum Hypertens; 2011 Jul; 25(7):451-6. PubMed ID: 20811397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the clonidine-suppression test in the diagnosis of pheochromocytoma.
    Plewe G; Krause U; Cordes U; Beyer J
    Klin Wochenschr; 1988 Sep; 66(17):764-7. PubMed ID: 3184760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of the clonidine suppression test in the diagnosis of pheochromocytoma.
    Karlberg BE; Hedman L
    Acta Med Scand Suppl; 1986; 714():15-21. PubMed ID: 3472437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonidine suppression test for pheochromocytoma: examples of misleading results.
    Taylor HC; Mayes D; Anton AH
    J Clin Endocrinol Metab; 1986 Jul; 63(1):238-42. PubMed ID: 3711261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonidine-suppression test in epinephrine secreting pheochromocytoma: report of a case.
    Dupont AG; Vanderniepen P; Gerlo E; Somers G; Vanhaelst L; in't Veld P; Gepts W; Sacre R; Six RO
    J Endocrinol Invest; 1985 Apr; 8(2):153-6. PubMed ID: 4031382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonidine suppression test reliably differentiates phaeochromocytoma from essential hypertension.
    Bachmann AW; Gordon RD
    Clin Exp Pharmacol Physiol; 1991 May; 18(5):275-7. PubMed ID: 2065469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Test with clonidine for diagnosing pheochromocytoma].
    Wocial B; Chojnowski K; Chodakowska J; Feltynowski T; Lazecki D; Januszewicz W
    Pol Tyg Lek; 1991 Aug 26-Sep 2; 46(35-36):641-5. PubMed ID: 1845684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clonidine suppression test for pheochromocytoma. A review of its utility and pitfalls.
    Sjoberg RJ; Simcic KJ; Kidd GS
    Arch Intern Med; 1992 Jun; 152(6):1193-7. PubMed ID: 1599347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonidine suppression test revisited.
    Lenz T; Ross A; Schumm-Draeger P; Schulte KL; Geiger H
    Blood Press; 1998 May; 7(3):153-9. PubMed ID: 9758085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonidine-induced suppression of plasma catecholamines in states of adrenal medulla hyperfunction.
    Gross MD; Shapiro B; Sisson JC; Zweifler A
    J Endocrinol Invest; 1987 Aug; 10(4):359-64. PubMed ID: 2890683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of clonidine suppression and various provocation tests in the diagnosis of pheochromocytoma.
    Koshida H; Miyamori I; Soma R; Matsubara T; Okamoto S; Ikeda M; Takeda R
    J Endocrinol Invest; 1990 Nov; 13(10):807-15. PubMed ID: 2096157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis of pheochromocytoma and paraganglioma: the clonidine suppression test in patients with borderline elevations of plasma free normetanephrine].
    Därr R; Lenders JW; Stange K; Kindel B; Hofbauer LC; Bornstein SR; Eisenhofer G
    Dtsch Med Wochenschr; 2013 Jan; 138(3):76-81. PubMed ID: 23299341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonidine suppression test--an evaluation of its diagnostic significance in hypertensive patients.
    Choudhury R; Sagar S; Ganguly NK; Sharma BK; Khullar M
    Indian Heart J; 1989; 41(3):162-7. PubMed ID: 2777299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased platelet catecholamine content in pheochromocytoma: a diagnostic test in patients with elevated plasma catecholamines.
    Zweifler AJ; Julius S
    N Engl J Med; 1982 Apr; 306(15):890-4. PubMed ID: 7062972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic significance of the clonidine suppression test in suspected pheochromocytoma].
    Stimpel M; Schürmeyer T; Ivens K; Wambach G; Volkmann HP; von zur Mühlen A
    Dtsch Med Wochenschr; 1988 Jan; 113(4):130-4. PubMed ID: 3338391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High permanent plasma adrenaline levels: a marker of adrenal medullary disease in medullary thyroid carcinoma.
    Vistelle R; Grulet H; Gibold C; Chaufour-Higel B; Delemer B; Fay R; Delisle MJ; Caron J
    Clin Endocrinol (Oxf); 1991 Feb; 34(2):133-8. PubMed ID: 1673649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bilateral adrenal pheochromocytoma. Diagnosis and follow-up using the clonidine test and measurement of plasma neuropeptide Y concentration].
    Eisenhut S; Rascher W; Lang RE
    Monatsschr Kinderheilkd; 1990 Sep; 138(9):631-4. PubMed ID: 2233767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Usefulness of the clonidine test for the diagnosis of pheochromocytoma].
    Mediavilla García JD; León-Ruiz L; Hidalgo Tenorio C; López de la Torre Casares M; Piédrola Maroto G; Pinel Julián P; Fernández-Torres C; Jiménez-Alonso J
    Rev Clin Esp; 2001 May; 201(5):245-8. PubMed ID: 11458792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results.
    Eisenhofer G; Goldstein DS; Walther MM; Friberg P; Lenders JW; Keiser HR; Pacak K
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2656-66. PubMed ID: 12788870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.